Myocardial Contrast Two-dimensional Echocardiography: Developments in Cardiovascular Medicine, cartea 99
Editat de Meerbaum, Richard S. Meltzeren Limba Engleză Hardback – 30 sep 1989
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1367.08 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 30 sep 2011 | 1367.08 lei 6-8 săpt. | |
Hardback (1) | 1373.82 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 30 sep 1989 | 1373.82 lei 6-8 săpt. |
Din seria Developments in Cardiovascular Medicine
- 5% Preț: 1484.48 lei
- 5% Preț: 375.14 lei
- 5% Preț: 354.09 lei
- 5% Preț: 1378.27 lei
- 5% Preț: 365.70 lei
- 5% Preț: 1066.75 lei
- 5% Preț: 1397.07 lei
- 5% Preț: 366.05 lei
- 5% Preț: 357.88 lei
- 5% Preț: 369.43 lei
- 5% Preț: 2056.67 lei
- 5% Preț: 356.82 lei
- 5% Preț: 356.13 lei
- 5% Preț: 360.54 lei
- 5% Preț: 360.39 lei
- 5% Preț: 760.76 lei
- 5% Preț: 692.76 lei
- 5% Preț: 1066.75 lei
- 5% Preț: 364.81 lei
- 5% Preț: 362.86 lei
- 5% Preț: 703.21 lei
- 5% Preț: 1072.43 lei
- 5% Preț: 2056.32 lei
- 5% Preț: 695.57 lei
- 5% Preț: 361.44 lei
- 5% Preț: 701.65 lei
- 5% Preț: 641.19 lei
- 5% Preț: 364.65 lei
- 5% Preț: 1382.36 lei
- 5% Preț: 694.88 lei
- 5% Preț: 768.04 lei
- 5% Preț: 700.05 lei
- 5% Preț: 3093.79 lei
- 5% Preț: 1377.54 lei
- 5% Preț: 762.16 lei
- 5% Preț: 694.17 lei
- 5% Preț: 360.19 lei
- 5% Preț: 365.52 lei
- 5% Preț: 641.93 lei
- 5% Preț: 357.88 lei
Preț: 1373.82 lei
Preț vechi: 1446.12 lei
-5% Nou
Puncte Express: 2061
Preț estimativ în valută:
262.90€ • 276.51$ • 219.67£
262.90€ • 276.51$ • 219.67£
Carte tipărită la comandă
Livrare economică 08-22 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792302056
ISBN-10: 0792302052
Pagini: 236
Ilustrații: XIV, 236 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.54 kg
Ediția:1989
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0792302052
Pagini: 236
Ilustrații: XIV, 236 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.54 kg
Ediția:1989
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1. Introduction and general background.- 1. Evolution of echo contrast concepts.- 2. Assessment of cardiac structures and flow patterns.- 3. Development of echo contrast agents.- 4. Consideration of echo contrast mechanism and safety.- References.- 2. Development and validation of MC-2DE methodology.- 1. Initial exploration of MC-2DE and its validity.- 2. Characteristics and studies of myocardial echo contrasts.- 3. Echo contrast safety and toxicity.- 4. Transpulmonary echo contrast investigations.- 5. Quantitative MC-2DE methods and their limitations.- 6. MC-2DE measurement of ischemic risk area and infarcts.- 7. Assessment of coronary stenosis and myocardial blood flow.- 8. Physiological studies and miscellaneous MC-2DE applications.- 9. Initial clinical MC-2DE reports.- 10. Potential surgical application of MC-2DE.- References.- 3. Contrast agents for myocardial perfusion studies: Mechanisms, state of the art, and future prospects.- 1. Introduction.- 2. The source of ultrasonic contrast effect.- 3. Physical influences on ultrasonic contrast effect.- 4. Specific agents reported as echocardiographic contrast agents.- 5. The use of high intensity sonication for microbubble creation.- 6. Conclusion.- Acknowledgements.- References.- 4. Significance and selection of contrast solution for myocardial contrast echocardiography.- 1. Introduction.- 2. Current echo contrast media.- 3. Properties of the ECM: Microbubble size, osmolality, viscosity, and stability.- 4. Evaluation of the echo contrast media used so far.- 5. Echo contrast safety and effectiveness.- 6. Some conclusions.- Acknowledgements.- References.- 5. Side effects and potential toxicity of myocardial contrast echo Cardiography.- 1. Introduction.- 2. Possible mechanisms of toxicity.- 3. Animal studies.- 4. Human experience.- 5. Conclusions.- References.- 6. Ischemic ‘risk area’ determination using myocardial contrast two-dimensional echocardiography.- 1. What is the ‘risk area’?.- 2. What is the significance of the ‘risk area’ ?.- 3. A historical perspective to the measurement of ‘risk area’.- 4. Role of MCE is the assessment of ‘risk area’.- 5. The lateral borders of the ‘risk area’.- 6. Summary.- Acknowledgements.- References.- 7. Quantitation of regional myocardial perfusion using myocardial contrast two-dimensional echocardiography.- 1. Coronary blood flow versus nutrient (myocardial) blood flow.- 2. Large microbubbles and blood flow.- 3. Small microbubbles and blood flow.- 4. Summary.- Acknowledgements.- References.- 8. Coronary venous myocardial contrast echocardiography.- 1. The rational of retrograde infusions.- 2. Experimental retrograde MC-2DE models.- 3. Experimental observations.- 4. Suitability and limitations of the retrograde MC-2DE method.- 5. Future retrograde MC-2DE potentials and prospects 148 References.- 9. Assessment of contrast decay half life by MC-2DE: Preliminary clinical experience.- 1. Introduction.- 2. Echocontrast agents.- 3. Registration of myocardial contrast echocardiograms.- 4. Analysis of MC-2DE images.- 5. T50 values derived from MC-2DE.- 6. Safety of MC-2DE.- 7. Reproducibility of T50 measurements.- 8. Clinical applications of T50.- 9. Limitations and future prospects.- References.- 10. Clinical trials with a new myocardial contrast agents.- 1. Introduction.- 2. Qualitative contrast echocardiography in humans.- 3. Quantitative contrast echocardiography in humans.- 4. Future directions.- Acknowledgements.- References.- 11. Clinical evaluation of severity of coronary arterial stenosis by contrast echomyocardiography.- 1.Introduction.- 2. Method.- 3. Results.- 4. Discussion.- 5. Summary.- References.- 12. Clinical applications of myocardial contrast echocardiography.- 1. Introduction.- 2. Myocardial contrast echocardiography in relation to regional myocardial perfusion.- 3. Contrast echocardiography during coronary angioplasty.- 4. Assessment of coronary vascular reserve by myocardial contrast echocardiography.- 5. Safety of myocardial contrast echocardiography in humans.- 6. Limitations.- 7. Perspectives and future directions.- Acknowledgement.- References.- 13. The issue of an intravenous MC-2DE methodology. A typical early study.- Section One: Recapitulation of problems and potentials by the volume-editor Samuel Meerbaum.- Section Two: Evaluation of myocardial echo enhancement by intra venous contrast echomyography in dogs.- Section Three: Present developments, progress and prospects by the volume-editor Samuel Meerbaum.- References.- 14. Current perspective and future prospects.- 1. General MC-2DE capabilities and limitations.- 2. Quantitation of myocardial perfusion.- 3. Efforts aimed at clinical application.- 4. Future prospects.
Recenzii
`This book is a must for those interested in this subject matter.'
C. Visser, Dutch Magazine on Medicine, 20, 1990
`It was a pleasure reviewing this publication ... of interest to internists and cardiac physiologists ... this is a very important book, related to a rapidly emerging exciting technique. Reading it was both intellectually and scientifically satisfying.'
Cardiology, 77/4, 1990
C. Visser, Dutch Magazine on Medicine, 20, 1990
`It was a pleasure reviewing this publication ... of interest to internists and cardiac physiologists ... this is a very important book, related to a rapidly emerging exciting technique. Reading it was both intellectually and scientifically satisfying.'
Cardiology, 77/4, 1990